Rchr
J-GLOBAL ID:201801006045617668   Update date: Apr. 17, 2024

Tomizawa Daisuke

トミザワ ダイスケ | Tomizawa Daisuke
Affiliation and department:
Job title: Head, Division of Leukemia and Lymphoma
Other affiliations (1):
  • Tokyo Medical and Dental University  Clinical professor
Research field  (1): Fetal medicine/Pediatrics
Research theme for competitive and other funds  (1):
  • 2013 - 2015 Significance of KIR Ligand Mismatched Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Infants
Papers (293):
  • Hirozumi Sano, Keitaro Fukushima, Michihiro Yano, Shinya Osone, Yoko Kato, Daiichiro Hasegawa, Takako Miyamura, Shotaro Iwamoto, Hiroyuki Takahashi, Kiminori Terui, et al. Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study. International journal of hematology. 2024
  • Kentaro Fujimori, Norihito Ikenobe, Yoshihiro Gocho, Toru Uchiyama, Takao Deguchi, Hirotoshi Sakaguchi, Daisuke Tomizawa, Ichiro Takeuchi, Hirotaka Shimizu, Katsuhiro Arai, et al. Hematopoietic stem cell transplantation in two sisters with bone marrow failure associated with POLE gene variants. Pediatric blood & cancer. 2024. e30919
  • Akihiro Iguchi, Toru Uchiyama, Kentaro Fujimori, Yoshihiro Gocho, Hirotoshi Sakaguchi, Takao Deguchi, Daisuke Tomizawa, Ken-Ichi Imadome, Masafumi Onodera, Kimikazu Matsumoto. HLA-haploidentical T-cell receptor αβT/B-cell-depleted stem cell transplantation for Fanconi anemia. International journal of hematology. 2024
  • Takahiro Aoki, Norio Shiba, Shinichi Tsujimoto, Genki Yamato, Yusuke Hara, Shota Kato, Kenichi Yoshida, Seishi Ogawa, Yasuhide Hayashi, Shotaro Iwamoto, et al. High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factor. Pediatric blood & cancer. 2023. e30803
  • Daisuke Tomizawa, Jun Matsubayashi, Shotaro Iwamoto, Hidefumi Hiramatsu, Daisuke Hasegawa, Hiroshi Moritake, Daiichiro Hasegawa, Kiminori Terui, Asahito Hama, Shin-Ichi Tsujimoto, et al. High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia. Leukemia. 2023
more...
MISC (201):
  • 安江志保, 坂口大俊, 藤森健太郎, 内山徹, 八角高裕, 大野沙耶香, 金裕花, 樋口徹, 牛腸義宏, 井口晶裕, et al. A case of an infant with familial hemophagocytic lymphohistiocytosis type 2 treated with cord blood transplantation. 日本小児科学会雑誌. 2024. 128. 2
  • 坂口大俊, 蘇哲民, 小須賀基通, 牛腸義宏, 出口隆生, 井口晶裕, 富澤大輔, 松本公一. Hematopoietic Cell Transplantation and Intracerebroventricular Enzyme Replacement for Mucopolysaccharidosis type II. 日本小児科学会雑誌. 2024. 128. 2
  • Genki Yamato, Tomoko Kawai, Norio Shiba, Yusuke Hara, Kentaro Ohki, Taeko Kaburagi, Etsuko Ishikita, Hirohide Kawasaki, Kenichi Yoshida, Yuichi Shiraishi, et al. Prognosis of Pediatric Acute Myeloid Leukemia with KMT2A-MLLT3 According to DNA Methylation Patterns: Jccg JPLSG AML-05 Study. BLOOD. 2022. 140. 9134-9135
  • Hiroki Yoshihara, Takako Miyamura, Takao Deguchi, Toshinori Hori, Tomohiko Taki, Kunihiko Moriya, Yuki Arakawa, Mariko Eguchi, Kunihiro Shinoda, Yuhki Koga, et al. IMMUNOPHENOTYPIC AND CHROMOSOMAL CHARACTERIZATION OF KMT2A GERMLINE ACUTE LYMPHOBLASTIC LEUKEMIA IN INFANTS. PEDIATRIC BLOOD & CANCER. 2022. 69
  • 藤森健太郎, 坂口大俊, 坂本淳, 寳月啓太, 松井俊大, 清水聡一郎, 池邉記人, 湊苑子, 森田麻莉, 豊原美環子, et al. Three pediatric cases of refractory gut GVHD successfully treated by Vedolizumab. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
more...
Education (2):
  • 2006 - 2010 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences Department of Pediatrics and Developmental Biology
  • 1993 - 1999 Tokyo Medical and Dental University Faculty of Medicine
Professional career (2):
  • MD (Tokyo Medical and Dental University)
  • PhD (Tokyo Medical and Dental University)
Work history (9):
  • 2018/06 - 現在 National Center for Child Health and Development Children's Cancer Center Head, Division of Leukemia and Lymphoma
  • 2014/09 - 2018/05 National Center for Child Health and Development Children's Cancer Center Chief, Division of Leukemia and Lymphoma
  • 2010/04 - 2014/08 University Hospital of Medicine, Tokyo Medical and Dental University Department of Pediatrics Assistant professor
  • 2004/08 - 2006/03 Postgraduate School of Medicine, Tokyo Medical and Dental University Department of Pediatrics and Developmental Biology Assistant professor
  • 2004/04 - 2004/08 University Hospital of Medicine, Tokyo Medical and Dental University Department of Pediatrics Medical fellow
Show all
Awards (8):
  • 2022/07 - Best Doctors in Japan 2022-2023
  • 2021/11 - The Japanese Society of Pediatric Hematology / Oncology The 11th Academic Award of the Japanese Society of Pediatric Hematology/Oncology A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial
  • 2021/04 - Japan Pediatric Society 2021 JPS Scientific Research Award Establishing standard of care for infants with acute lymphoblastic leukemia
  • 2021/03 - Japanese Society for Hematopoietic Cell Transplantation JSHCT Working Group Research Award Allogeneic Hematopoietic Stem Cell Transplantation for Adolescents and Young Adults with Acute Myeloid Leukemia
  • 2016/11 - NPO Japan Leukemia Research Fund General Research Award
Show all
Association Membership(s) (8):
International Society of Pediatric Oncology ,  The American Society of Hematology ,  THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY ,  Japanese Society of Medical Oncology ,  Japan Society for Hematopoietic Cell Transplantation ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY ,  JAPAN PEDIATRIC SOCIETY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page